The Latest

Medical device and pharma news and information

Medical Device and Pharmaceutical News

The latest information of interest to regulated industry. Bookmark this page to have a quick review for

    • FDA enforcement news
    • Regulatory updates
    • Innovative products
    • Compliance information, and
    • Other industry headlines.

And do not forget to check our pages for consumer safety information and regulatory services.

Eugia Vancomycin Recall: Glass Particle Contamination

FDA announces voluntary recall of a single lot of vancomycin hydrochloride for injection because of potentially dangerous particulate contamination.Eugia US LLC, formerly Auro Medics Pharma LLC, has initiated a voluntary nationwide recall of one lot of Vancomycin...

read more

FDA Requires New GLP-1 Drug Warning for Vision Loss Risk

Agency cites potential increased risk of rare optic nerve condition following review of clinical trials and postmarket safety dataThe U.S. Food and Drug Administration (FDA) is requiring manufacturers of all glucagon-like peptide-1 receptor agonist (GLP-1 RA)...

read more

Class 1 Recall for HemosIL AcuStar HIT Antibody Test

HemosIL AcuStar HIT-IgG(PF4-H). Source: fda.govPerformance problems could produce false-negative results, potentially delaying diagnosis of a dangerous reaction to heparin.The U.S. Food and Drug Administration (FDA) has identified a recall of certain lots of the...

read more

Closing the Arterial Opening Without Surgery

Vivasure Medical's PerQseal Elite offers a minimally invasive approach to closing large arterial openings following cardiovascular procedures.Vivasure Medical's PerQseal Elite offers a minimally invasive approach to closing large arterial openings following...

read more

FDA Approves Amplatzer Paraclose for Heart Valve Leaks

Abbott's Amplatzer Paraclose PVL Occluder offers a minimally invasive alternative for patients who develop a significant complication following heart valve replacement surgery.Heart valve replacement surgery can be lifesaving for patients with damaged or diseased...

read more

FDA Approves Treatment for Advanced Head and Neck Cancer

Rybrevant Faspro receives accelerated approval following promising clinical trial results in patients with limited treatment options.The U.S. Food and Drug Administration (FDA) announced on November 5, 2026, that it has granted accelerated approval to Rybrevant Faspro...

read more

FDA Approves Treatment that Targets SMA Muscle Loss

Isembyld introduces a new treatment approach for patients with SMA by addressing muscle weakness alongside existing therapies targeting the underlying genetic disease.The U.S. Food and Drug Administration (FDA) has approved Isembyld (apitegromab-mstn), the first...

read more

October 2026 Premarket Approval (PMA) Authorizations

Three original device approvals and 218 supplements / noticesFDA's October activity highlights three newly approved medical devices and the extensive regulatory oversight required to maintain and modify products already on the market.The U.S. Food and Drug...

read more

FDA Cell and Gene Therapy Potency Guidance

Eight Practical Implications for ManufacturersFDA's November 2026 final guidance moves beyond potency testing to emphasize a comprehensive, risk-based strategy for assuring product potency throughout development, manufacturing, and patient delivery.FDA'S final...

read more